Another CRL Prompts Questions About Regeneron’s Regulatory Operations

 
• By Alaric DeArment

CEO Len Schleifer explained on the company’s Q1 earnings call that most of the complete response letters the company has received related to third-party suppliers, not efficacy or safety.

Regeneron headquarters
• Source: Shutterstock

More from Earnings

More from Scrip